SpectraBase Spectrum ID |
KJRBZzYkPu1 |
Name |
Nandrolone FORM |
Classification |
Pharmaceutical drug derivative |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (f) (64) |
DEA Controlled Substance Name |
nandrolone |
DEA Controlled Substance Type |
Salts, esters and ethers |
DEA Controlled Substances Code Number |
4000 |
DEA Schedule |
Schedule III |
DEA Section |
Anabolic Steroids. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any quantity of the following substances, including its salts, esters and ethers. |
Exact Mass |
302.188194694 u |
Formula |
C19H26O3 |
InChI |
InChI=1S/C19H26O3/c1-19-9-8-15-14-5-3-13(21)10-12(14)2-4-16(15)17(19)6-7-18(19)22-11-20/h10-11,14-18H,2-9H2,1H3/t14-,15+,16+,17-,18-,19-/m0/s1 |
InChIKey |
VTJPCIHYJUPQQW-ZOFHRBRSSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
302.414 g/mol |
Nominal Mass |
302 u |
Quality |
994 |
Retention Index |
2483 |
SMILES |
[C@]12([C@@]([C@@]3(C(CC2)=CC(CC3)=O)[H])(CC[C@]2([C@]1(CC[C@@]2(OC=O)[H])[H])C)[H])[H] |
SPLASH |
splash10-0bu1-3920000000-5a44c98e859ad8426b43 |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
(1S,3aS,3bR,9aR,9bS,11aS)-11a-methyl-7-oxo-2,3,3a,3b,4,5,7,8,9,9a,9b,10,11,11a-\rtetradecahydro-1H-cyclopenta[a]phenanthren-1-yl formate |
Technique |
GC/MS |
Wiley ID |
DD2024_011797 |